Abstract Library

#1251 Biodistribution and Radiation Dosimetry of a Novel 18F-Fluoroethyl Triazole [Tyr3] Octreotate Analogue for PET Imaging Patients with Advanced Neuroendocrine Tumours.

Introduction: Despite advances, detection and quantification of NET activity by imaging remains a challenge.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: DUBASH S

Authors: Dubash S, Keat N, Mapelli P, Twyman F, Carroll L,

Keywords: PET,

#317 Paraganglioma: Gallium-68 DOTOTATE PET CT Scanning, a Useful Addition to MIBG Scanning in Metastatic Disease

Introduction: Nuclear imaging forms an important part of the assessment of chromaffin cell tumors. MIBG scintigraphy has been available for some time, while 68Ga-DOTATATE PET CT is increasingly utilized.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Joharatnam J, Carroll R, Ghaffar A, Al-Nahhas A, Meeran K,

Keywords: phaeochromocytoma, paraganglioma, nuclear imaging, MIBG, Gallium-68 DOTATATE,

#289 Gallium-68 DOTATATE PET CT Frequently Changes Patient Management or Staging When Compared with Indium-111 Octreotide in the Assessment of Neuroendocrine Tumors

Introduction: 68Ga-DOTATATE PET CT offers higher resolution than previous octreotide-labelled scintigraphic techniques, and the literature suggests increased sensitivity for the localization and staging of NETs.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Carroll R, Comminos A, Frilling A, Meeran K, Al-Nahhas A,

Keywords: Gallium-68 DOTATATE PET CT, Indium-111 Octreotide, neuroendocrine tumor,

#287 Lutetium-177 DOTATATE Therapy in the Management of Neuroendocrine Tumors

Introduction: Peptide receptor radionuclide therapy (PRRT) is a specific targeted treatment for NETs expressing somatostatin receptors. 177Lu-DOTATATE is one of several newly available compounds for this treatment.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Carroll R, Tan T, Todd J, Al-Nahhas A, Bomanji J,

Keywords: 177Lutetium-DOTATATE therapy, neuroendocrine tumor, paraganglioma, SDHB,

#283 Primary Lymph Node Gastrinoma: A Genuine Entity? Two Case Reports and a Review of the Literature

Introduction: The existence of primary lymph node gastrinoma has been proposed but is controversial. We report two cases (Case A - 37-year-old male, Case B - 43-year-old male) of apparent primary lymph node gastrinoma.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Carroll R, Martin J, Tan T, Goldstone A, Spalding D,

Keywords: primary lymph node gastrinoma, gastrinoma of unknown primary site, lymph node metastases,